Enter assignee name

% Expired Patents = 83.3

CIPO Patents = 1

EPO Patents = 5

Trademarks = 1

Forward Citations = 62

Loading Chart...

19 inventors (with patents filed for the assignee):

Christopher M Starr (3 out of 19 patents)

Todd C Zankel (3 out of 16 patents)

Nigel H Greig (2 out of 27 patents)

4. Gordon Powers (2 out of 24 patents)

5. Harold W Holloway (2 out of 17 patents)

6. Donald K Ingram (2 out of 6 patents)

7. Arnold Brossi (2 out of 25 patents)

8. Karen T Y Shaw (2 out of 4 patents)

9. Qiang-Sheng Yu (2 out of 4 patents)

10. Tada Utsuki (2 out of 4 patents)

11. Timothy T Soncrant (2 out of 6 patents)

12. Diane M Davidson (2 out of 4 patents)

13. Reinhard Gabathuler (2 out of 5 patents)

14. Michael Alan Sturgess (2 out of 9 patents)

15. Anthony J Giordano (2 out of 12 patents)

6 patents: Sort by Forward Citations

1. 8877714 - Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereof (2014-11-04),

2. 8258172 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof (2012-09-04),

3. 7977317 - Compositions and methods for modulating blood-brain barrier transport (2011-07-12),

4. 7786162 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof (2010-08-31),

5. 7569544 - Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents (2009-08-04),

6. 7560431 - Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents (2009-07-14),

Raptor Pharmaceutical Corp is a biopharmaceutical company focused on developing and commercializing transformative therapies for rare diseases. With a strong emphasis on research and development, Raptor is dedicated to addressing unmet medical needs and improving the lives of patients with rare disorders. Their innovative approach to drug development has led to the successful launch of several groundbreaking therapies in the rare disease space.

Profile summary based on public USPTO records.